Latest filing published 03 Mar 2026 for Usana Health Sciences INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joshua Foukas, listed as senior executive, appears in our data through filings on Usana Health Sciences Inc shares, published by SEC (Form 4). Between 23 July 2021 and 27 February 2026, the trades on record add up to 22 filings.
The open-market record consists of 8 sales worth €1.0M, with no purchase. Besides market trades, the filings include 14 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 3 March 2026 came the latest disclosure, an option exercise in Usana Health Sciences Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations